Browse All

Current Filters

CLEAR FILTER x

TITLE

Phase II/III Study of Ulviprubart in Inclusion Body Myositis: Study Design, Patient Characteristics, and Topline Results

Author:Goyal, Namita A.   Machado, Pedro M.   Ascherman, Dana P.   Benveniste, Olivier   Beydoun, Said R.   Brannagan, Thomas H.   Christopher-Stine, Lisa   Collins, Michael P.   De Bleecker, Jan L.   Dimachkie, Mazen   Dixon, Stacy   Fernandez, David R.   Freimer, Miriam   Geiger, Christopher   Gonzalez-Perez, Paloma   Goyal, Neelam   Gwathmey, Kelly   Heitzman, Daragh   Henderson, Robert D.   Hodson-Webb, Lisa D.   Hussain, Yessar   Korngut, Lawrence   Liang, Christina   Lilleker, James B.   Lloyd, Thomas   Mohassel, Payam   Naddaf, Elie   Needham, Merrilee   Piccione, Ezequiel   Quinn, Colin C.   Rosow, Laura   Roy, Bhaskar   Ruck, Tobias   Schmidt, Jens   Seth, Arjun   Shah, Jaimin   Shaibani, Aziz   Shieh, Perry B.   Simmons, Zachary   Sivakumar, Kumaraswamy   Wang, Leo H.   Weihl, Conrad C.   Wilkins, H. Jeffrey   Amato, Anthony   

Session Name:S7: Updates on Muscle Disorders  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S7.007  

Author Institution:

Sustained Clinical Efficacy and Long-term Safety of Intravenous Efgartigimod for Generalized Myasthenia Gravis: Part B of ADAPT NXT

Author:Seth, Arjun   Hussain, Yessar   Habib, Ali   Claeys, Kristl   Sahagian, Gregory   Cortés-Vicente, Elena   Guptill, Jeffery   Liu, Li   Jimenez, Rosa   Bougamra, Sirine   Masschaele, Delphine   Mantegazza, Renato   Meisel, Andreas   Attarian, Shahram   

Session Name:P9: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis Clinical Trials  

Topic:Pain  

Program Number:P9.003  

Author Institution: